Pembrolizumab-induced Guillain-Barré syndrome in triple-negative breast cancer: A case report

doi:10.5306/wjco.v16.i2.97823

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (198)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

HTML

108

Figures (1-1)

Tables (1-1)

Sum=153

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=39

Feb 24, 2025 (publication date) through Dec 18, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Oncol. Feb 24, 2025; 16(2): 97823
Published online Feb 24, 2025. doi: 10.5306/wjco.v16.i2.97823

Open in New Tab Full Size Figure Download Figure

Figure 1 Magnetic resonance imaging of the lumbar spine. A: Abnormal enhancement and clumping of the cauda equina nerve roots suggested inflammatory pathology, and given the patient’s history, arrow: Guillain-Barré syndrome; B: Abnormal cauda equina nerve root enhancement suggested inflammatory pathology, and given the patient’s history, arrow: Guillain-Barré syndrome.

Citation: Cherukuri PB, Tayyeb M, Gaddameedi SR, Du D, Meghal T. Pembrolizumab-induced Guillain-Barré syndrome in triple-negative breast cancer: A case report. World J Clin Oncol 2025; 16(2): 97823
URL: https://www.wjgnet.com/2218-4333/full/v16/i2/97823.htm
DOI: https://dx.doi.org/10.5306/wjco.v16.i2.97823